STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Trump has promised to not touch Medicare or Social Security, and wants to increase the defense budget. That makes Medicaid a target for spending cuts.

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

During his election night speech, Trump reiterated his promise to give RFK Jr. a role on health care policy. “He’s going to help make America healthy again… He’s a great guy and he really means that ...

Novo Nordisk disclosed it knows of 10 deaths and 100 hospitalizations from people taking compounded copies of its weight loss ...

Donald Trump has been called the winner of the election. As STAT’s Sarah Owermohle writes, Trump’s second term as president ...

With Donald Trump’s victory in the presidential election, public health experts are anxiously waiting to see whether his ...

Massachusetts voters on Tuesday rejected Question 4, the ballot measure that proposed decriminalizing the use of psychedelic ...

The president-elect campaigned on promises to shake up public health institutions, reshape federal health programs, and slash ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

Political scientist Kevin Smith says his research suggests “political orientations are at least partially under genetic ...

The last decade has seen a swell of biotech startups using AI to design proteins. These are seven companies to watch.